Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析

◆英語タイトル:Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH180702FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus) manufactures and distributes gene engineering drugs and preventive biological products. The company’s products include recombinant human interferon a-2b injection, used to treat hepatitis and cancers; recombinant human interleukin-2, an injection developed for killing cancer cells by increasing the growth of T lymphocytes and B lymphocytes; and subunit influenza vaccine. It also conducts research for developing cytokines products and vaccines. The company markets its products across China. Neptunus is headquartered in Shenzhen, China.

Shenzhen Neptunus Interlong Bio-Technique Co Ltd Key Recent Developments

Feb 26,2021: Shenzhen Neptunus Interlong Bio-technique Company : appointment of non-executive Director

This comprehensive SWOT profile of Shenzhen Neptunus Interlong Bio-Technique Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shenzhen Neptunus Interlong Bio-Technique Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Information
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Overview
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Employees
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Employee Biographies
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Operational Heads
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Major Products and Services
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – History
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Company Statement
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Locations And Subsidiaries
Shenzhen Neptunus Interlong Bio-Technique Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Business Description
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Corporate Strategy
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Strengths
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Weaknesses
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Opportunities
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Threats
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Information
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Ratios
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Share Data
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Major Products and Services
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, History
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Employees
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Employee Biographies
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Operational Heads
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Other Locations
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Subsidiaries
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Competitors
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, SWOT Analysis
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Ratios based on current share price
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Annual Ratios
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Concord New Energy Group Ltd (182):企業の財務・戦略的SWOT分析
    Concord New Energy Group Ltd (182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Knight Square Holdings Ltd:企業の戦略・SWOT・財務情報
    Knight Square Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Knight Square Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and of …
  • Brii Biosciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Brii Biosciences is an independent biotechnology company that focuses on developing and commercializing innovative medicines for infectious diseases, liver and lung diseases, and other chronic diseases. The company strives to advance breakthroughs in science and technology, and enable patien …
  • PharmAthene Inc (PIP)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bios …
  • Brixmor Property Group Inc:企業の戦略・SWOT・財務情報
    Brixmor Property Group Inc - Strategy, SWOT and Corporate Finance Report Summary Brixmor Property Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Marr S.P.A.
    Marr S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Marr S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Infratil Ltd (IFT)-エネルギー分野:企業M&A・提携分析
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • Porton Pharma Solutions Ltd (300363):企業の財務・戦略的SWOT分析
    Summary Porton Pharma Solutions Ltd (Porton) is involved in the supply of intermediate drugs and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It is also involved in providing research and development and produc …
  • Inmarsat Plc (ISAT):企業の財務・戦略的SWOT分析
    Inmarsat Plc (ISAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • B. Braun Melsungen AG:医療機器:M&Aディール及び事業提携情報
    Summary B. Braun Melsungen AG (B. Braun) develops, manufactures and distributes medical technology and pharmaceutical products, and provides medical services worldwide. The company’s major products include solutions and disposables for infusion, nutrition and pain therapy, infusion pumps and systems …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TC Pipelines LP (TCP):石油・ガス:M&Aディール及び事業提携情報
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • ARUP Laboratories:企業の戦略的SWOT分析
    ARUP Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • 3M Company:企業のM&A・事業提携・投資動向
    3M Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3M Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • BWX Technologies Inc (BWXT):電力:M&Aディール及び事業提携情報
    Summary BWX Technologies Inc (BWXT) is a specialty manufacturer of nuclear components. It designs, engineers, and manufactures precision naval nuclear components, reactors, and nuclear fuel for the US Government. The company also provides special nuclear materials processing and environmental site r …
  • Digna Biotech SL-製薬・医療分野:企業M&A・提携分析
    Summary Digna Biotech SL (Digna) is a biotechnology company that specializes in the development and commercialization of robust clinical therapeutic candidates. The company’s pipeline portfolio includes cutaneous manifestation of scleroderma, clinical indications for kidney transplant and liver surg …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆